Intravenous Access Devices Market Report

Intravenous Access Devices Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 20, 2020
  • PAGES：200
  • REPORT CODE：GMM442491
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Intravenous Access Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.

    This report presents the market size and development trends by detailing the Intravenous Access Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intravenous Access Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intravenous Access Devices industry and will help you to build a panoramic view of the industrial development.

    Intravenous Access Devices Market, By Type:

    • Intravenous Catheters

    • Intravenous Infusion Pumps

    • Intravenous Needles

    Intravenous Access Devices Market, By Application:

    • Hospitals

    • Clinics

    • ASCs

    • Dialysis centers

    • Home care

    Some of the leading players are as follows:

    • Terumo

    • Vygon

    • Angiodynamics

    • Exelint

    • Medtronic

    • Global Medikit

    • Galtneedletech

    • Baxter

    • Apexmed

    • Vigmed

    • Retractable Technologies

    • Nipro Medical

    • BD

    • Promed Group

    • Cook Medical

    • Delta Med

    • Renovorx

    • Fresenius

    • ICU Medical

    • Hospira

    • Teleflex

    • Smiths Medical

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Intravenous Access Devices Market: Technology Type Analysis

    • 4.1 Intravenous Access Devices Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Intravenous Access Devices Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Intravenous Catheters

      • 4.3.2 Intravenous Infusion Pumps

      • 4.3.3 Intravenous Needles

    5 Intravenous Access Devices Market: Product Analysis

    • 5.1 Intravenous Access Devices Product Market Share Analysis, 2018 & 2026

    • 5.2 Intravenous Access Devices Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Intravenous Access Devices Market: Application Analysis

    • 6.1 Intravenous Access Devices Application Market Share Analysis, 2018 & 2026

    • 6.2 Intravenous Access Devices Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospitals

      • 6.3.2 Clinics

      • 6.3.3 ASCs

      • 6.3.4 Dialysis centers

      • 6.3.5 Home care

    7 Intravenous Access Devices Market: Regional Analysis

    • 7.1 Intravenous Access Devices Regional Market Share Analysis, 2018 & 2026

    • 7.2 Intravenous Access Devices Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Terumo

      • 9.1.1 Terumo Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Vygon

      • 9.2.1 Vygon Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Angiodynamics

      • 9.3.1 Angiodynamics Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Exelint

      • 9.4.1 Exelint Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Medtronic

      • 9.5.1 Medtronic Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Global Medikit

      • 9.6.1 Global Medikit Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Galtneedletech

      • 9.7.1 Galtneedletech Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Baxter

      • 9.8.1 Baxter Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Apexmed

      • 9.9.1 Apexmed Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Vigmed

      • 9.10.1 Vigmed Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Retractable Technologies

      • 9.11.1 Retractable Technologies Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Nipro Medical

      • 9.12.1 Nipro Medical Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 BD

      • 9.13.1 BD Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Promed Group

      • 9.14.1 Promed Group Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Cook Medical

      • 9.15.1 Cook Medical Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Delta Med

      • 9.16.1 Delta Med Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Renovorx

      • 9.17.1 Renovorx Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Fresenius

      • 9.18.1 Fresenius Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 ICU Medical

      • 9.19.1 ICU Medical Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 Hospira

      • 9.20.1 Hospira Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

    • 9.21 Teleflex

      • 9.21.1 Teleflex Company overview

      • 9.21.2 Financial performance

      • 9.21.3 Product benchmarking

      • 9.21.4 Strategic initiatives

      • 9.21.5 SWOT analysis

    • 9.22 Smiths Medical

      • 9.22.1 Smiths Medical Company overview

      • 9.22.2 Financial performance

      • 9.22.3 Product benchmarking

      • 9.22.4 Strategic initiatives

      • 9.22.5 SWOT analysis

     

    The List of Tables and Figures (Totals 86 Figures and 160 Tables)

    • Figure Intravenous Catheters Intravenous Access Devices market, 2015 - 2026 (USD Million)

    • Figure Intravenous Infusion Pumps Intravenous Access Devices market, 2015 - 2026 (USD Million)

    • Figure Intravenous Needles Intravenous Access Devices market, 2015 - 2026 (USD Million)

    • Figure Hospitals market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure ASCs market, 2015 - 2026 (USD Million)

    • Figure Dialysis centers market, 2015 - 2026 (USD Million)

    • Figure Home care market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Intravenous Access Devices market, by country, 2015 - 2026 (USD Million)

    • Table North America Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table North America Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table North America Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Canada Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Canada Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Access Devices market, by country, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Germany Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Germany Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table France Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table France Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Italy Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Italy Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Spain Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Spain Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Access Devices market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table China Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table China Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Japan Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Japan Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table India Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table India Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Access Devices market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Access Devices market, by country, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Intravenous Access Devices market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Intravenous Access Devices market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Intravenous Access Devices market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Terumo Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Vygon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Angiodynamics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Exelint Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Medtronic Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Global Medikit Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Galtneedletech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Baxter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Apexmed Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Vigmed Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Retractable Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Nipro Medical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Promed Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cook Medical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Delta Med Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Renovorx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fresenius Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ICU Medical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hospira Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teleflex Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Smiths Medical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US